You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / MOREPEN LABORATORIES

MOREPEN LABORATORIES
Intrinsic Value | Fundamental Analysis

Returns | 1W : 2.2% , 1M : 13.4%,1Y : 137.9%
www.morepen.com
BOM : 500288     NSE : MOREPENLAB    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : Average
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Sep 17,2021
Price(EOD): Rs. 60.15
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Affiliate Link.
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
MOREPEN LABORATORIES 2.2% 13.4% 137.9%
SUN PHARMACEUTICAL INDUSTRIES -1.3% -1.8% 54.5%
DR REDDYS LABORATORIES -0.9% 4% 12.1%
DIVIS LABORATORIES 0.8% 4.4% 63.9%
CIPLA 0.4% 5.5% 31.5%
BIOCON 6.8% 2.9% -12.9%
AUROBINDO PHARMA 1.3% 2% -6%
LUPIN -3.4% -2.4% 0.1%
TORRENT PHARMACEUTICALS -0.9% 3% 9.7%


FUNDAMENTAL ANALYSIS OF MOREPEN LABORATORIES

 
Fundamentals Score
[ Q(TTM): Jun2021, Y: Mar2020
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]
Show Me the Stocks with Fundamentals better than MOREPEN LABORATORIES Plus/Pro


VALUATION OF MOREPEN LABORATORIES

 
Valuation Score
[As on : Sep 17,2021 ]

Ratio Standalone
P/E
P/B
P/S
83.54
P/E Calculated based on EPS of 0.72
[ Mar2020 - Standalone Results ]

8.81
P/B Calculated based on Book Value of 6.83
[ Mar2020 - Standalone Results ]

2.19
P/S Calculated based on Revenues of 1234.4 Cr
[ TTM - Standalone Results ]

Show Me the Stocks with Valuation better than MOREPEN LABORATORIES Plus/Pro


FAIR VALUE OF MOREPEN LABORATORIES

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
62%
-12%
72%

SHARE PRICE MOMENTUM OF MOREPEN LABORATORIES

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0.43
0.47
0.53
0.48
0.47
0.52
0.06
0.35
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
0 %
As on : Jun2021

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
38.29%
54.22%
53.6%
22.69%
50.14%
68.73%
104.93%
63.69%
QtrlyTrend
8
Latest Qtr: Jun2021

MOREPEN LABORATORIES related INDICES

BSE Indices1W1M1Y
S&P BSE ALLCAP 1.2% 6.3% 61.2%
S&P BSE MIDSMALLCAP 0.8% 7.5% 84%
S&P BSE SMALL CAP 0.5% 6.6% 94.4%
S&P BSE HEALTHCARE -0.2% 1.3% 42.6%
No NSE index found

FAQ [Frequently Asked Questions]


Is MOREPEN LABORATORIES good for long term investment?

As on 17-Sep-2021, the Fundamentals of MOREPEN LABORATORIES look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of MOREPEN LABORATORIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is MOREPEN LABORATORIES UnderValued or OverValued?

As on 17-Sep-2021, MOREPEN LABORATORIES is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of MOREPEN LABORATORIES ?

As on 17-Sep-2021, the Intrinsic Value of MOREPEN LABORATORIES is Rs. 37.03 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 37.03
Fair Value [Median EV / Sales Model] : Rs. 68.47
Fair Value [Median Price / Sales Model] : Rs. 34.95
Median Fair Value of MOREPEN LABORATORIES : Rs. 37.03

Is MOREPEN LABORATORIES trading at a Premium or Discount?

As on 17-Sep-2021, MOREPEN LABORATORIES is trading at a Premium of 62% based on the estimates of Median Intrinsic Value!

What is the Financial Performance of Industry Peers of MOREPEN LABORATORIES ?

Check out Annual Financials of Industry Peers
Share Price & Financials of SUN PHARMACEUTICAL INDUSTRIES LTD | BOM: 524715 | NSE: SUNPHARMA
Share Price & Financials of DR REDDYS LABORATORIES LTD | BOM: 500124 | NSE: DRREDDY
Share Price & Financials of DIVIS LABORATORIES LTD | BOM: 532488 | NSE: DIVISLAB
Share Price & Financials of CIPLA LTD | BOM: 500087 | NSE: CIPLA
Share Price & Financials of BIOCON LTD | BOM: 532523 | NSE: BIOCON
Check out Quarterly Results of Industry Peers
Quarterly Results of SUN PHARMACEUTICAL INDUSTRIES LTD
Quarterly Results of DR REDDYS LABORATORIES LTD
Quarterly Results of DIVIS LABORATORIES LTD
Quarterly Results of CIPLA LTD
Quarterly Results of BIOCON LTD

What are the Frequent Comparisons in this Industry?

Compare Analytics
SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD vs DIVIS LABORATORIES LTD
CIPLA LTD vs BIOCON LTD vs AUROBINDO PHARMA LTD
LUPIN LTD vs TORRENT PHARMACEUTICALS LTD vs CADILA HEALTHCARE LTD
ABBOTT INDIA LTD vs ALKEM LABORATORIES LTD vs PIRAMAL ENTERPRISES LTD
GLAXOSMITHKLINE PHARMACEUTICALS LTD vs IPCA LABORATORIES LTD vs PFIZER LTD
Browse Market Cap of Industry Peers
Market Cap of SUN PHARMACEUTICAL INDUSTRIES LTD
Market Cap of DR REDDYS LABORATORIES LTD
Market Cap of DIVIS LABORATORIES LTD
Market Cap of CIPLA LTD
Market Cap of BIOCON LTD

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z